Drugs / Ty800
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00269295 | Feb 2006 → Jan 2007 | typhoid fever | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00498654 | Jul → Oct 2007 | typhoid fever | Avant Immunotherapeutics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ty800 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00498654 ↗ |
| Modality | Vaccine | “Live attenuated Ty800 S typhi oral vaccine” NCT00269295 ↗ |
| Route | Oral | “Ty800 oral typhoid vaccine” NCT00269295 ↗ |